South Korea
Celltrion announces acquisition of iQone Healthcare Switzerland, accelerating direct commercialization of its biosimilars in the European region T...
November 18, 2024 | News
Pioneering Korea's ARPA-H Project: Focused on mRNA Vaccine Room-Temperature Storage and Extra-Long-Term Preservation Creating a Platform for Prolonged R...
November 04, 2024 | News
Neurophet enters into a strategic agreement with LADO to distribute Neurophet SCALE PET Improves the efficiency of market entry with expertise of medica...
October 31, 2024 | News
Avance Clinical, a leading full-service global Contract Research Organization (CRO), has announced the signing of three pivotal Memorandums of Understandin...
October 30, 2024 | News
GC Biopharma announced that it has signed an agreement with Novelty Nobility, a biotech company specializing in the development of antibody-based therapeut...
October 29, 2024 | News
Qurient has announced the commencement of a clinical trial for adrixetinib (formerly named Q702), following the clearance of its investigational new drug (...
October 25, 2024 | News
Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading environment while maintaining or improving screening qua...
October 24, 2024 | News
This approval paves the way for exports to the world's fourth most populous country. SK bioscience aims to continue to grow as a global vaccine brand be...
October 23, 2024 | News
Thermo Fisher Scientific is proud to announce the successful conclusion of its highly anticipated Bioprocess World Tour 2024 in the Asia-Pacific and Japan ...
October 23, 2024 | News
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel...
October 23, 2024 | News
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced a contract manufacturing deal with an As...
October 23, 2024 | News
This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug in South...
October 21, 2024 | News
This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug in South...
October 18, 2024 | News
Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease - Collabor...
October 16, 2024 | News
Most Read
Bio Jobs
News